From: Prognostic factors for ARDS: clinical, physiological and atypical immunodeficiency
Variables | Acute respiratory distress syndrome |  |  | ∆P-value | |
---|---|---|---|---|---|
Total | Mild | Moderate | Severe | Â | |
Number | 201 | 31 | 61 | 109 | Â |
Age,years | 54.24 ± 16.35 | 55.38 ± 15.60 | 52.43± | 54.93 ± 16.03 | 0.579 |
Sex,male/female,n | 130/71 | 19:12 | 40/21 | 71/38 | 0.415 |
BMI,kg/m2 | 23.90 ± 3.82 | 24.22 ± 3.93 | 23.83 ± 4.05 | 23.90 ± 3.82 | 0.896 |
Cause of ARDS | |||||
 Pneumonia | 125 | 19 | 37 | 69 |  |
 Non-pulmonary spesis | 38 | 6 | 15 | 17 |  |
 Pancreatitis | 15 | 4 | 7 | 4 |  |
 Trauma | 7 | 0 | 0 | 7 |  |
 Aspiration | 2 | 0 | 0 | 2 |  |
 Others | 14 | 2 | 2 | 10 |  |
APACHE II score | 14.19(7.69 to 31.00) | 12.74(7.69 to 24.37) | 14.52 (9.86 to 27.69) | 14.34 (9.68 to 31.00)* | 0.016 |
SOFA score | 4.98(4.65 to 5.30) | 4.59(3.97 to 5.20) | 5.11 (4.71 to 5.53) | 5.26 (4.89 to 5.63) | 0.027 |
PaO2/FiO2,mmHg | 123 (112 to 134) | 280 (267 to 294) | 140 (132 to 146)* | 69 (65 to 72)* # | 0.000 |
CRP,mg/L | 129.82 (129.82 to 169.91) | 110.09 (76.59 to 143.59) | 163.90 (138.67 to 189.14)* | 203.33 (115.97 to 290.68)* | 0.011 |
PCT,ng/ml | 12.20 (8.12 to 16.29) | 9.37 (5.45 to 13.30) | 10.15 (1.51 to 18.80) | 17.05 (7.58 to 27.73)* | 0.175 |
Albumin,g/L | 27.67 ± 5.82 | 27.13 ± 3.17 | 27.07 ± 6.05 | 28.10 ± 6.05* | 0.759 |
Hemoglobin,g/L | 107.67 ± 28.32 | 104.04 ± 23.76 | 107.29 ± 28.05 | 108.82 ± 29.73 | 0.759 |
Leukocytes,109/L | 11.33(10.12 to 12.54) | 10.98 (8.67 to 13.28) | 10.91 (9.62 to 12.22) | 13.65 (8.65 to 18.64) | 0.298 |
Lymphocytes,109/L | 1.10 (0.95 to 1.26) | 1.28 (0.86 to 1.75) | 1.10 (8.67 to 13.28) | 1.07 (0.87 to 1.27)* | 0.025 |
Neutrophils,109/L | 10.78 (8.38 to 13.18) | 8.35 (6.91 to 9.78) | 11.66 (7.59 to 15.74) | 13.03 (7.31 to 18.76) | 0.371 |
Lymphocyte/Neutrophil ratio | 0.19 ± 0.03 | 0.35 ± 0.23 | 0.17 ± 0.03* | 0.15 ± 0.02* | 0.001 |
Virus infection,n,% | 23(11.44%) | 1(3.23%) | 10(16.39%) | 12(11.0%) | Â |
28-day mortality,n,% | 103(51.24%) | 13(41.94%) | 31(50.82%) | 59(54.13%) | Â |
100-day mortality,n,% | 121(60.20%) | 15(48.39%) | 37(60.66%) | 69(63.30%) | Â |
Immunoglobulin | Â | Â | Â | Â | Â |
IgG,g/L | 10.87 ± 1.86 | 11.71 ± 4.96 | 10.82 ± 1.94 | 10.59 ± 5.36 | 0.095 |
IgA,g/L | 1.98 ± 0.24 | 1.92 ± 1.09 | 1.85 ± 0.72 | 2.11 ± 1.40 | 0.270 |
IgM,g/L | 1.05 ± 0.86 | 1.32 ± 1.18 | 1.02 ± 0.92 | 1.00 ± 0.72 | 0.598 |
IgE,ng/mL | 620.36 ± 145.11 | 1426.20 ± 119.89 | 640.55 ± 32.45 | 356.87 ± 78.73* | 0.025 |
Complement components | |||||
 C3 | 5.62 ± 1.78 | 12.27 ± 1.83 | 7.13 ± 3.14 | 0.84 ± 0.33* | 0.186 |
 C4 | 1.33 ± 0.58 | 0.25 ± 0.13 | 0.24 ± 0.11 | 2.25 ± 0.95* | 0.663 |
T-lymphocytes subsets | |||||
 CD3+ cells,% | 62.75 ± 15.29 | 71.00 ± 13.78 | 63.35 ± 12.44 | 60.62 ± 17.11 | 0.229 |
 CD4+ cells,% | 35.15 ± 15.48 | 36.40 ± 13.69 | 34.10 ± 11.14 | 35.66 ± 8.47 | 0.951 |
 CD4+ cells count (PCS/ul) | 383.20 ± 67.18 | 176.50 ± 67.18 | 383.67 ± 94.79 | 434.08 ± 78.66 | 0.708 |
 CD8+ cells,% | 27.33 ± 13.46 | 34.33 ± 6.37 | 25.60 ± 11.59 | 26.92 ± 14.01 | 0.275 |
 CD8+ cells count (PCS/ul) | 212.33 ± 64.30 | 134.00 ± 30.63 | 286.67 ± 51.72 | 178.91 ± 70.96 | 0.409 |
 CD4+/CD8+ ratio | 1.95 ± 0.26 | 1.29 ± 0.23 | 1.91 ± 0.93 | 2.14 ± 0.48 | 0.623 |
B-lymphocytes | |||||
 B-lymphocytes,% | 30.25 ± 17.28 | 18.00 ± 3.24 | 26.20 ± 7.81 | 33.36 ± 7.81 | 0.598 |
 B-lymphocytes cell count (PCS/μl) | 301.05 ± 73.77 | 69.01 ± 8.89 | 413.20 ± 41.42 | 271.18 ± 78.37 | 0.665 |
NK cell | |||||
 NK cells,% | 8.76 ± 5.91 | 17.00 ± 4.41 | 9.40 ± 0.81 | 7.73 ± 4.58 | 0.331 |
 NK cell count (PCS/ul) | 68.77 ± 46.46 | 68.20 ± 7.66 | 82.60 ± 14.82 | 62.55 ± 15.15 | 0.751 |